News | August 12, 2014

The Christie Hospital Joins Elekta and Philips Research Consortium to Develop MRI-Guided Radiotherapy System

August 12, 2014 — Elekta and Philips Healthcare announced The Christie NHS Foundation Trust, a specialist cancer center based in Manchester, England, will join a consortium whose mission is to develop the clinical value of an integrated magnetic resonance imaging (MRI)-guided radiation therapy system. Such a system would, in principle, improve the practice of radiotherapy via real-time visualization of cancer targets.

"The Christie was an essential participant in the project 14 years ago that laid the foundations of the use of cone beam computed tomography [CBCT] at the time of treatment to improve radiotherapy delivery," said Niklas Savander, Elekta president and CEO. "It has a dedicated team of researchers in medical physics, radiotherapy and clinical oncology, and MR imaging that is committed to the most accurate and individualized delivery of radiation therapy. The Christie has the perfect blend of experience and expertise to further help the consortium make MRI-guided radiation therapy a reality."

The Christie is the seventh member to join the research consortium that assesses the novel technology, which brings together state-of-the-art radiation therapy and MRI in a single system. The consortium also includes the University Medical Center Utrecht (the Netherlands), the University of Texas MD Anderson Cancer Center (Houston), the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam), Sunnybrook Health Sciences Centre (Toronto), the Froedtert & Medical College of Wisconsin Cancer Center (Milwaukee) and the Institute of Cancer Research, working with its clinical partner the Royal Marsden NHS Foundation Trust (London).

"We are very excited to be a part of an international consortium of truly exceptional centers that are striving as we are to develop technological innovations to benefit patients," said Ananya Choudhury, Ph.D., MRCP, FRCR, consultant and honorary senior clinical lecturer, clinical oncology at The Christie. "Unlike any imaging modality now in use in combination with radiotherapy, MRI can provide highly detailed images of the tumor and surrounding normal tissues. Moreover, MRI will permit physicians to noninvasively visualize and track the target during beam delivery – real-time imaging – which will further improve treatment accuracy."

The Christie joined the recent research consortium meeting at Utrecht, where the clinical indications that would benefit the most from the use of MRI-guided radiation therapy were discussed. These targets are typically going to be in anatomy that changes its position and shape either from day to day or during the treatment. The consortium anticipates the use of MRI imaging at the time of treatment will result in a considerable increase in the accuracy of the placement of the dose, reducing the need for large safety margins around the tumor target.

"When we first started this journey with Elekta and the University Medical Center Utrecht more than a decade ago, we already had a clear vision, yet we could only dream of today's MRI imaging performance," said Gene Saragnese, CEO, imaging systems at Philips Healthcare. "Since then we have come a long way, and I am convinced that with the current state of the technology and the growing consortium of leaders in radiation therapy delivery, we have the prerequisites to make the integrated MRI-guided radiation therapy technology a game changer in cancer care."

For more information: www.elekta.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...